Praxis Precision Medicines, Inc. PRAX Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s common stock, shares authorized (in shares)?
- Praxis Precision Medicines, Inc. (PRAX) reported common stock, shares authorized (in shares) of $150M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Praxis Precision Medicines, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $150M to $150M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $150M to $150M.